Search results
- 1.0551303 - ÚI 2022 GB eng A - Abstract
Cibula, D. - Havel, L. - Zemanová, M. - Pešek, M. - Kolek, V. - Spíšek, R. - Bartůňková, J. - Pecen, Ladislav - Krasnopolskaya, I. - Černovská, M.
Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 36, 15 S (2018), s. 9051. ISSN 0732-183X. E-ISSN 1527-7755
Permanent Link: http://hdl.handle.net/11104/0326730 - 2.0551302 - ÚI 2022 GB eng A - Abstract
Rob, L. - Mallmann, P. - Knapp, P. - Melichar, B. - Klat, J. - Minář, L. - Novotný, Z. - Bartůňková, J. - Spíšek, R. - Pecen, Ladislav - Bin Hassan, H. I. - Cibula, D.
Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 36, 15 S (2018), s. 5509. ISSN 0732-183X. E-ISSN 1527-7755
Permanent Link: http://hdl.handle.net/11104/0326729 - 3.0521311 - MBÚ 2020 US eng A - Abstract
Adkins, I. - Sadílková, I. - Hradilová, N. - Tomala, Jakub - Tomalová, Barbora - Kovář, Marek - Mikysková, R. - Reiniš, Milan - de Martynoff, G. - Bechard, D. - Moebius, U. - Spíšek, R.
Use of RLI-15 a clinical grade fusion protein with IL-15 superagonistic activity for the activation of anti-tumor immune response.
Cancer Research. American Association for Cancer Research. Roč. 78, 13 S (2018). ISSN 0008-5472. E-ISSN 1538-7445.
[Annual Meeting of the American-Association-for-Cancer-Research (AACR). 14.04.2018-18.04.2018]
Institutional support: RVO:61388971
Keywords : RLI-15 * IL-15 * carcinoma
OECD category: Microbiology
Permanent Link: http://hdl.handle.net/11104/0305937 - 4.0506303 - ÚI 2020 US eng A - Abstract
Cibula, D. - Rob, L. - Mallmann, P. - Knapp, P. - Bartůňková, J. - Spíšek, R. - Hassan, H. I. - Pecen, Ladislav - Klat, J. - Chovanec, J.
Dendritic cell-based immunotherapy (DCVAC/OvCa) withchemotherapy in patients with platinum-sensitive, relapsed,epithelial ovarian carcinoma: Survival analysis of a phase II,open-label, randomized, multicenter trial (study SOV02).
Gynecologic Oncology. Elsevier. Roč. 154, suppl. 1 (2019), s. 18-18. ISSN 0090-8258. E-ISSN 1095-6859.
[Annual Meeting of the Society of Gynecologic Oncology /50./. 16.03.2019-19.03.2019, Honolulu]
Institutional support: RVO:67985807
Permanent Link: http://hdl.handle.net/11104/0297589 - 5.0506302 - ÚI 2020 eng A - Abstract
Havel, L. - Kolek, V. - Pešek, M. - Černovská, M. - Bartůňková, J. - Spíšek, R. - Pecen, Ladislav - Krasnopolskaya, I. - Zemanová, M.
Dendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 37, suppl (2019), s. 9039-9039. ISSN 0732-183X. E-ISSN 1527-7755
https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.9039
Permanent Link: http://hdl.handle.net/11104/0297588 - 6.0506294 - ÚI 2020 eng A - Abstract
Havel, L. - Zemanová, M. - Pešek, M. - Kolek, V. - Spíšek, R. - Bartůňková, J. - Pecen, Ladislav - Krasnopolskaya, I. - Černovská, M.
Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial.
Journal of Clinical Oncology. Roč. 36, 15 suppl (2018), s. 9051-9051. ISSN 0732-183X. E-ISSN 1527-7755
Permanent Link: http://hdl.handle.net/11104/0297583